Get started
Author

Torsten Holm Nielsen

Observed names: Holm Nielsen, Torsten, T H Nielsen, T. H. Nielsen, T. Nielsen, T.H. Nielsen, Torsten H. Nielsen, Torsten Holm H Nielsen
Observed institutions: University of Copenhagen, Roskilde Sygehus, Danish Medicines Agency, Jewish General Hospital, Herlev Hospital, Copenhagen University Hospital, Gentofte Hospital, Rigshospitalet, Zealand University Hospital, Lady Davis Institute for Medical Research, McGill University
ORCID: 0009-0000-7309-3859
Observed ORCID: 0009-0000-7309-3859
OpenAlex ID: A5034004011
Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas
2015 · Ryan D. Morin, Sarit Assouline, et al. · Clinical Cancer Research · 233
Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma
2016 · Sarit E. Assouline, Torsten Holm Nielsen, et al. · Blood · 146
A systematic review and meta-analysis of beta-blockers and renin–angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer
2021 · Christian Lewinter, Torsten Holm Nielsen, et al. · European Heart Journal · 107
Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate
1992 · H. K. Iversen, T. H. Nielsen, et al. · European Journal of Clinical Pharmacology · 65
Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance
2013 · D Dupéré-Richer, M Kinal, et al. · Cell Death and Disease · 55
PDF
The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia
2013 · F Hariri, M Arguello, et al. · Leukemia · 38
COVID-19-associated pancytopenia can be self-limiting and does not necessarily warrant bone marrow biopsy for the purposes of SARS-CoV-2 diagnostics
2020 · D.S. Hersby, T.H. Do, et al. · Annals of Oncology · 26
PDF
Efficacy of intravenous high-dose methotrexate in preventing relapse to the central nervous system in R-CHOP(-like)-treated, high-risk, diffuse large B-cell lymphoma patients and its effect on mortality: a systematic review and meta-analysis
2024 · Elisabeth R. Tolley, Christian Lewinter, et al. · Haematologica · 17
PDF
Lack of effect of GR43175 on peripheral arteries in man.
1989 · T H Nielsen, P Tfelt-Hansen · PubMed · 12
Next generation sequencing in routine diagnostics of mature non‐Hodgkin 's B‐cell lymphomas
2023 · Marie Fredslund Breinholt, Lone Schejbel, et al. · European Journal Of Haematology · 11
Sexual dysfunction is highly prevalent in male survivors of malignant lymphoma
2023 · Signe Micas Pedersen, Torsten Holm Nielsen, et al. · Sexual Medicine · 11
PDF
Incidence and characterization of secondary CNS lymphoma in 1972 patients with DLBCL: a Danish nationwide cohort study
2024 · Elisabeth Reuben Tolley, Torsten Holm Nielsen, et al. · Blood Advances · 9
Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice
2024 · Simon Østergaard, Lone Schejbel, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 8
Multi-site pre-therapeutic biopsies demonstrate genetic heterogeneity in patients with newly diagnosed diffuse large B-cell lymphoma
2023 · Ditte Stampe Hersby, Lone Schejbel, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 6
Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia: A Case Report and Prevalence in a Nationwide Population-Based Cohort Study
2022 · Khazra Bhatti, Aqsa Nazir, et al. · Journal of Hematology · 6
PDF
Methods for Sample Acquisition and Processing of Serial Blood and Tumor Biopsies for Multicenter Diffuse Large B-cell Lymphoma Clinical Trials
2014 · Torsten Holm Nielsen, Zuanel Diaz, et al. · Cancer Epidemiology Biomarkers & Prevention · 6
Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient
2013 · Torsten H. Nielsen, Nathalie Johnson, et al. · Frontiers in Pharmacology · 6
PDF
Extramedullary disease in Waldenström macroglobulinemia: A population‐based observational study
2024 · Simon Østergaard, Lars Munksgaard, et al. · eJHaem · 4
PDF
Inactivating BTK mutations in large B‐cell lymphoma in a real‐world cohort: Strong correlation with BCL2 translocation
2022 · Lone Schejbel, Marie Fredslund Breinholt, et al. · eJHaem · 3
PDF
Increased protein processing gene signature in HDACi-resistant cells predicts response to proteasome inhibitors
2016 · Daphné Dupéré-Richer, Mena Kinal, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 3
Core Needle Biopsies in Patients With Lymphoproliferative Malignancies: An Observational Single‐Center Cohort Study
2025 · Blas Holger Mogensen, Torsten Holm Nielsen, et al. · European Journal Of Haematology · 2
PDF
Central nervous system involvement in Waldenström macroglobulinemia: a comparative population-based study of Bing-Neel syndrome and histological transformation
2025 · Simon Østergaard, Lars Munksgaard, et al. · Annals of Hematology · 2
PDF
Limited Benefit of Routine Clinical Follow‐Up for Relapse Detection in Diffuse Large B‐Cell Lymphoma Patients in Complete Remission Following First‐Line Treatment
2025 · Therese Lassen, Torsten H. Nielsen, et al. · American Journal of Hematology · 2
PDF
‘Ablate and pace’ reduces mortality in heart failure patients with atrial fibrillation: an updated meta-analysis
2026 · Christian Lewinter, John G F Cleland, et al. · European Heart Journal Open · 1
TP53 Mutation Is the Only Robust Mutational Biomarker for Outcome Found in a Consecutive Clinical Cohort of Real‐Word Patients With Primary Large B‐Cell Lymphoma
2024 · Marie Fredslund Breinholt, Lone Schejbel, et al. · European Journal Of Haematology · 1
Works count: 62
Citation count: 787
H-index: 11
I10-index: 11
Year
Topic
Type